Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients
about
Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide.Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain productionPlasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates.
P2860
Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Single-dose pharmacokinetics o ...... ciency virus-infected patients
@ast
Single-dose pharmacokinetics o ...... ciency virus-infected patients
@en
type
label
Single-dose pharmacokinetics o ...... ciency virus-infected patients
@ast
Single-dose pharmacokinetics o ...... ciency virus-infected patients
@en
prefLabel
Single-dose pharmacokinetics o ...... ciency virus-infected patients
@ast
Single-dose pharmacokinetics o ...... ciency virus-infected patients
@en
P2093
P2860
P1476
Single-dose pharmacokinetics o ...... ciency virus-infected patients
@en
P2093
P2860
P304
P407
P577
1997-12-01T00:00:00Z